• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保泰松片剂制剂中降解产物的鉴定

Identification of degradation products in a phenylbutazone tablet formulation.

作者信息

Matsui F, Robertson D L, Poirier M A, Lovering E G

出版信息

J Pharm Sci. 1980 Apr;69(4):469-71. doi: 10.1002/jps.2600690430.

DOI:10.1002/jps.2600690430
PMID:7373550
Abstract

Two previously reported but unidentified phenylburazone degradation products were isolated from a tablet that was stored at 60 degrees for 203 days. The compounds, alpha-(N-phenylcarbamoyl)-N-caproylhydrazobenzene and alpha-hydroxy-alpha-(N-phenylcarbamoyl)-N-caproylhydrazobenzene, were isolated by chromatography, identified by mass and NMR spectrometry, and synthesized by the reaction of aniline with phenylbutazone or its hydroxy analog, respectively.

摘要

从一片在60摄氏度下储存203天的药片上分离出了两种先前已报道但未鉴定的苯基布他松降解产物。通过色谱法分离出了化合物α-(N-苯基氨基甲酰基)-N-己酰基氢化偶氮苯和α-羟基-α-(N-苯基氨基甲酰基)-N-己酰基氢化偶氮苯,通过质谱和核磁共振光谱法进行了鉴定,并分别通过苯胺与苯基布他松或其羟基类似物的反应进行了合成。

相似文献

1
Identification of degradation products in a phenylbutazone tablet formulation.保泰松片剂制剂中降解产物的鉴定
J Pharm Sci. 1980 Apr;69(4):469-71. doi: 10.1002/jps.2600690430.
2
Determination of phenylbutazone in tablets by nuclear magnetic resonance spectrometry.通过核磁共振光谱法测定片剂中的保泰松
J Pharm Sci. 1984 Nov;73(11):1653-5. doi: 10.1002/jps.2600731145.
3
The varying dissolution rates of phenylbutazone tablets.保泰松片不同的溶出速率。
N Z Med J. 1970 Oct;72(461):250-3.
4
Mass spectral and pyrolytic behavior of the two main products of phenylbutazone degradation: simulation of unusual mass spectral fragmentation.保泰松降解两种主要产物的质谱和热解行为:异常质谱碎裂的模拟
J Pharm Sci. 1976 Jan;65(1):68-70. doi: 10.1002/jps.2600650113.
5
Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.用于测定片剂中保泰松和羟基保泰松的质子磁共振波谱法。
J Assoc Off Anal Chem. 1988 May-Jun;71(3):525-7.
6
[Pressure-course events in the tabletting of phenylbutazone].[保泰松压片过程中的压力变化情况]
Pharmazie. 1984 Oct;39(10):693-4.
7
[Mass spectrometric study on 3,5-dioxo-pyrazolidines and their methylation products].[3,5-二氧代吡唑烷及其甲基化产物的质谱研究]
Arch Pharm (Weinheim). 1972 May;305(5):334-7. doi: 10.1002/ardp.19723050504.
8
Stability-indicating assay for phenylbutazone: high-performance liquid chromatographic determination of hydrazobenzene and azobenzene in degraded aqueous phenylbutazone solutions.保泰松的稳定性指示测定法:高效液相色谱法测定降解的保泰松水溶液中的氢化偶氮苯和偶氮苯
J Pharm Sci. 1984 Dec;73(12):1706-9. doi: 10.1002/jps.2600731211.
9
Solid-state esterification of codeine phosphate by the acid constituent of effervescent tablets.泡腾片中酸性成分对磷酸可待因的固态酯化作用。
J Pharm Sci. 1987 Jan;76(1):53-5. doi: 10.1002/jps.2600760115.
10
Variability of uniformity of weight test as an indicator of the amount of active ingredient in tablets.重量均匀度测试的变异性作为片剂中活性成分含量的指标。
J Pharm Sci. 1967 Feb;56(2):233-5. doi: 10.1002/jps.2600560217.

引用本文的文献

1
Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
Pharm Weekbl Sci. 1986 Aug 22;8(4):229-33. doi: 10.1007/BF01957783.